7 min read
Monthly FDA Guidance and Regulatory News Review - April 2026
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
Join Veristat and oncology drug developers at the Clinical Operations in Oncology Trials West Coast 2017 event. The event aims to explore innovative strategies in patient recruitment and retention, site engagement and vendor management for better cost efficiency and high data quality in oncology trials.
The agenda includes topics that Veristat is well versed in such as:
Meet up with Veristat while you are at this event! Veristat’s experienced teams have helped clients run over 335 Oncology studies for solid tumors, hematologic malignancies and more. Additionally, we’ve worked on over 20 US and European regulatory submission projects for cancer treatments, including many rare cancers.
Don’t forget to stop by our booth #3 to meet with our experts to talk about the challenges you are facing with your clinical trial design, execution and regulatory submission projects.
Fill out the form on the right to schedule a specific time to meet with Jessica Young or Kimberly Britt at the conference.
7 min read
May 20, 2026 Veristat Blog
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
3 min read
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...